Journal article
Human pluripotent stem cells for the modelling of retinal pigment epithelium homeostasis and disease: A review
JC Hall, D Paull, A Pébay, GE Lidgerwood
Clinical and Experimental Ophthalmology | WILEY | Published : 2022
DOI: 10.1111/ceo.14128
Abstract
Human pluripotent stem cells (hPSCs), which include induced pluripotent stem cells and embryonic stem cells, are powerful tools for studying human development, physiology and disease, including those affecting the retina. Cells from selected individuals, or specific genetic backgrounds, can be differentiated into distinct cell types allowing the modelling of diseases in a dish for therapeutic development. hPSC-derived retinal cultures have already been used to successfully model retinal pigment epithelium (RPE) degeneration for various retinal diseases including monogenic conditions and complex disease such as age-related macular degeneration. Here, we will review the current knowledge gaine..
View full abstractRelated Projects (2)
Grants
Awarded by Dementia Australia Research Foundation
Funding Acknowledgements
Victorian Government; Dementia Australia Research Foundation, Grant/Award Number: 039305; Medical Research Future Fund -Stem Cell Therapies Mission, Grant/Award Number: MRF1200678; DHB Foundation; NHMRC Synergy, Grant/Award Number: 1181010; National Health and Medical Research Council (NHMRC) Senior Research Fellowship, Grant/Award Number: 1154389; Australian Research Council (ARC) Training Centre for Personalised Therapeutics Technologies, Grant/Award Number: IC170100016